GL1X · GenesisL1 explorer

MolNFT v1 · #167527 · protein

Cryo-EM structure of the C-terminal half of the PARKINSON'S disease- linked protein leucine rich repeat kinase 2 (LRRK2)

6VNO · Leucine-rich repeat SERINE/THREONINE-protein kinase 2: “Cryo-EM structure of the C-terminal half of the PARKINSON'S disease- linked protein leucine rich repeat…”. Electron microscopy, 2 ligands (GDP, MG), 20 pockets (best…

PDB
6VNO
Type
protein
Length
1,084 residues
Chains
1
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Leucine-rich repeat SERINE/THREONINE-protein kinase 2
EC
2.7.11.1, 3.6.5.-
UniProt
Q5S007
Ligands
GDP, MG
Pockets
20 · best druggability 0.75

Structure

electron microscopy · 1 distinct chain · 30% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALeucine-rich repeat SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 3.6.5.-)protein108430% helix, 28% strandQ5S007

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19870.750.7765empty
21070.710.9220empty
33460.700.8351empty
45940.690.7858empty
52270.650.8324empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 6VNO · Cryo-EM structure of the C-terminal half of the Parkinson's Disease-linked protein… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q5S007 · AlphaFold monomer V2.0 prediction for leucine-rich repeat SERINE/THREONINE-protein kinase… · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.